CRNX241220P00041000 Option on Crinetics Pharmaceuticals

CRNX Stock  USD 57.39  0.19  0.33%   

Crinetics Total Stockholder Equity

Total Stockholder Equity

566.06 Million

At this time, Crinetics Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year.

Crinetics Pharmaceuticals Corporate Management

Jeff KnightChief OfficerProfile
James HassardChief OfficerProfile
Adriana MBAChief OfficerProfile
Gayathri DiwakarHead RelationsProfile
Dana MDChief OfficerProfile
Robert MDSenior AffairsProfile

Additional Tools for Crinetics Stock Analysis

When running Crinetics Pharmaceuticals' price analysis, check to measure Crinetics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crinetics Pharmaceuticals is operating at the current time. Most of Crinetics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Crinetics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crinetics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Crinetics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.